We are very excited to confirm that Dr. Michael Schunk, Senior Director, Bulk Manufacturing at sanofi pasteur Canada will speak at our LSC2011!
With more than 13 years of experience in the industry, Dr. Schunk is responsible for viral and bacterial active ingredient manufacturing operations in multiple facilities on a large vaccine manufacturing and R&D (Research & Development) site in Toronto. He has also held a number of leadership positions at sanofi pasteur prior to his current role, most recently as the Senior Director, Quality Control at the Marcy L'Etoile site in France.
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, is the largest company in the world devoted entirely to human vaccines. The company offers the broadest range of vaccines in the world, providing protection against 20 bacterial and viral diseases, and it distributes more than 1.6 billion doses of vaccine each year, making it possible to vaccinate more than 500 million people across the globe.
Sanofi, formerly known as sanofi-aventis, is a multinational Fortune 500 pharmaceutical company headquartered in Paris, France, and is the fourth-largest by prescription sales in the world. As a diversified healthcare leader, Sanofi discovers, develops and distributes therapeutic solutions focused on patients’ needs. The company has core strengths in healthcare, with six growth platforms: emerging markets, vaccines, consumer healthcare, diabetes treatments, innovative products and animal health. Moreover, through the acquisition of Genzyme, Sanofi has strongly reinforced its footprint in rare diseases.
